Soy Isoflavone Aglycone Modulates A Hematopoietic Response in Combination with Soluble β-Glucan: SCG

Soy isoflavone aglycones (IFAs) have a wide range of biological actions that suggest they may be of use in cancer prevention. On the other hand, a branched β-glucan from Sparassis crispa (SCG) is a major 6-branched 1,3-β-D-glucan in an edible/medicinal mushroom: Sparassis crispa showing antitumor ac...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Biological & pharmaceutical bulletin 2005, Vol.28(12), pp.2342-2345
Hauptverfasser:	Harada, Toshie, Masuda, Susumu, Arii, Masayuki, Adachi, Yoshiyuki, Nakajima, Mitsuhiro, Yadomae, Toshiro, Ohno, Naohito
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Agaricales Animals beta-Glucans - chemistry beta-Glucans - pharmacology beta-Glucans - therapeutic use branched β-glucan from Sparassis crispa (SCG) Cell Proliferation - drug effects Disease Models, Animal Drug Administration Schedule Drug Synergism Drug Therapy, Combination Flow Cytometry Glycine max Hematopoiesis - drug effects hematopoietic response Hematopoietic System - drug effects Injections, Intraperitoneal Isoflavones - pharmacology Isoflavones - therapeutic use Leukocyte Count Leukopenia - chemically induced Leukopenia - drug therapy Male Mice Mice, Inbred ICR Plant Extracts Solubility soy isoflavone aglycone Soybean Proteins - pharmacology Soybean Proteins - therapeutic use Spleen - cytology Spleen - drug effects Time Factors β-glucan
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!